pipette
ENEnglish

Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction

Marius Messemaker, Bjørn P. Y. Kwee, Živa Moravec, Sam de Paauw, Jos H. M. Urbanus, Daniel Álvarez-Salmoral, Jeroen Geerligs, Ren Xie, Rhianne Voogd, Ben Morris, Aurélie Guislain, Yael Winkler, Connor A. Richterich, Maike Mussmann, Marijn Bakker, Maxime Steinmetz, Matyas Iras, Eric Marcus, Jonas Teuwen, Anastassis Perrakis, Roderick L. Beijersbergen, Wouter Scheper, Ton N. Schumacher

Revista con revisión por paresAfirmaciones fuertes, leer con cuidadoUso en el mundo real

En palabras de los autores

Accurate prediction of T cell receptor (TCR) reactivity is a long-standing goal in immunology. Here, we asked whether functional validation of TCR-peptide-major histocompatibility complex (MHC) (TCR-pMHC) pairs at scale alters performance estimates of TCR-pMHC reactivity prediction models. We developed a TCR rapid assembly platform (T-RAP) that allowed the generation of large and uniform TCR libraries. T-RAP enabled evaluation of TCR signaling or MHC multimer binding of thousands of previously reported TCR-pMHC pairs under standardized conditions. In this setting of systematic standardized evaluation, only ∼50% of these TCRs showed the previously reported TCR reactivity. Notably, AlphaFold3 structural predictions showed good performance in identifying reactive TCR-pMHC pairs within the set of TCRs that experimentally validated without any task-specific training. AlphaFold3 structural predictions could likewise be used to shortlist TCRs reactive to patient-specific cancer neoantigens. In silico prediction of TCR-pMHC reactivity thus has greater feasibility than previously assumed, with implications for basic research and clinical application.

Resultado principalEl resumen no menciona limitaciones.

Apareció: sábado, 3 de octubre. Immunity. Revista con revisión por pares.

DOI: 10.1016/j.immuni.2026.09.007